Comparedtonon-cancerpatientswhounderwentsimilarsurgeryTheriskofVTEincancerpatientsis4-6timeshigherthaninnon-cancerpatientsPatientsreceivingchemotherapyhada6.5foldincreasedriskofVTETheriskofDVTincancer
hemodialysisEnoxaparinisoneofthecommonlyusedanticoagulantsinhemodialysis1longhalf-life,asingleinjectioncanmaintain4-6hSmalldoseof2canmaintaintheeffectivenessofanticoagulationdialysisTherewerenobleedin
DeepvenousthrombosisofthelowerextremityStudieshaveconfirmedthatenoxaparinhasaclearefficacyinthetreatmentoflowerlimbdeepveinthrombosis,rarecomplicationssuchasbleeding,relativelyfewthrombocytopenia,none
ProgressivecerebralinfarctionMaoDejunwillwithin24hoursofonsetofthe312patientswithcerebralinfarctionwererandomlydividedinto2groups,theroutinetreatmentgroup(150caseswithconventionaltreatment,accordingto